FDA
approval
· 2022-05-17
FDA Approved: BUPRENORPHINE TRANSDERMAL SYSTEM — Original Application (Alvogen Inc.)
Summary
FDA approved an original ANDA for buprenorphine transdermal system (generic buprenorphine) for chronic pain management.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BUPRENORPHINE TRANSDERMAL SYSTEM (BUPRENORPHINE)